Purchases and Sales Made in Q4 2025 in Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL) during Q4 2025. The information is specifically focused on institutions that hold shares of Zentalis Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 29, 2026
Q4 2025
|
Ubs Group Ag
|
BUY
|
- |
142K+ 26.64% |
$182K - $257K
|
675K
$897K
|
|
|
Jan 26, 2026
Q4 2025
|
Cwm, LLC
|
SELL
|
- |
-4.55K- 34.72% |
$5.83K - $8.24K
|
8.56K
$11.4K
|
|
|
Jan 15, 2026
Q4 2025
|
Highline Wealth Partners LLC
Sherman Oaks, CA |
SELL
|
- |
-7K- 58.33% |
$8.96K - $12.7K
|
5K
$6.65K
|
|
|
Jan 08, 2026
Q4 2025
|
Wealth Enhancement Advisory Services, LLC
|
SELL
|
- |
-35.9K- 21.58% |
$45.9K - $64.9K
|
130K
$173K
|
|
|
Jan 29, 2026
Q4 2025
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-48.8K- 1.68% |
$62.5K - $88.3K
|
2.86M
$3.8M
|
|
|
Jan 28, 2026
Q4 2025
|
Peapod Lane Capital LLC
Bedford Hills, NY |
SELL
|
- |
-117K- 20.61% |
$149K - $211K
|
449K
$597K
|
|